Search Results for: CELL CULTURE MARKET 3D Cell
Articles
CELL CULTURE MARKET - 3D Cell Cultures: Next Generation & New Challenges November 19, 2015
Kevin James and Robert G. Hunter of BCC Research say significant growth within the biopharmaceuticals industry is spurring unprecedented innovation in and demand for cell culture products for the purposes of drug discovery and safety testing. While 2D cell cultures have been in laboratory use since the 1950s, the market for 3D cultures has witnessed spectacular growth throughout the past decade.
Cellular Origins Partners With ScaleReady to Simplify, Standardize & Automate Cell Therapy Manufacturing May 11, 2023
Cellular Origins recently announced a collaborative partnership with ScaleReady, a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf that brings together process development expertise, tools, and technologies for scalable CGT….
Microcarrier Market is Expected to Reach $2.9 Billion April 13, 2023
The microcarrier industry is expected to grow significantly in the near future. This is due to the increasing demand for...Evonik Launches New Peptide to Boost Productivity of Cell-Culture-Based Biopharmaceuticals June 7, 2022
Evonik now offers a highly pure cystine peptide to address challenges in the formulation of cell culture media and processes...Takara Bio Europe AB & PanCryos Announce Licensing Agreement to Enable Development of Cell-Based Therapy for Diabetes May 6, 2021
Takara Bio Europe AB (TBEAB) and PanCryos recently announce they have reached a licensing agreement surrounding TBEAB’s clinical-grade human embryonic stem (hES) cell lines…..
PromoCell Receives EXCiPACT Certification as Manufacturer of Pharmaceutical Excipients to GMP Standards January 28, 2021
PromoCell, one of the leading European manufacturers of human cell culture and cell biology products, has recently announced to have...PromoCell Now Offers In Vitro Disease Models That Could Lead to New Therapies November 14, 2019
PromoCell now offers cell disease models covering a wide range of diseases, including diabetes type 1 and 2, respiratory diseases,...International Stem Cell Corporation Developed 3D Liver Structures August 13, 2018
International Stem Cell Corporation recently announced that ISCO’s Research and Development team has developed novel methods that efficiently generate human...Pfanstiehl Launched New cGMP-Produced Galactose for Cell Culture Media Optimization & Production of Therapeutic Recombinant Glycoproteins June 13, 2018
As part of Pfanstiehl’s continual commitment to producing the industry’s highest purity, lowest endotoxin and lowest metals (HPLE-LM) for bioprocessing components, two new D-Galactose products have been launched.
CELL THERAPY - PLX-R18: Cell Therapy for Treatment of Acute Radiation Syndrome & Bone Marrow Failure Diseases February 28, 2017
Racheli Ofir, PhD, and Noa Sher, PhD, report on studies showing that PLX-R18 is a strong candidate for the treatment of H-ARS as well as a plethora of bone marrow failures with similar symptomatology.
The Promise of Stem Cell Research Yields Double-Digit Growth Rates May 31, 2016
Although products based on stem cells have yet to form an established market, unlike some other potential applications of bioscience,...SINGLE-USE MARKET - Rise of Single-Use Technologies & Systems in Biopharmaceuticals November 19, 2015
Kevin James and Shalini S. Dewan of BCC Research believe eliminating the risk of contamination is the greatest challenge faced by manufacturers of biopharmaceuticals, and currently, this requires high-level monitoring of critical manufacturing processes. Single-use technology aids biopharmaceutical manufacturers in overcoming this challenge by reducing or eliminating the need for sterilization between batches, thereby improving operational efficiency.
Lonza to Expand Availability of 3D Cell Culture System July 13, 2015
Lonza has announced that it has reached an exclusive agreement with TAP Biosystems, part of the Stedim Biotech Group, to...Protea Biosciences & InSphero AG Enter to Combine 3D Technologies July 15, 2014
Protea Biosciences Group, Inc. and InSphero AG jointly announced they have entered into a collaboration that will combine each company's...Ascendia Pharmaceuticals Develops Novel Nanoemulsion IV Formulation for Clopidogrel That Received IND Approval June 26, 2023
Ascendia Pharmaceuticals CEO Jim Huang, PhD, recently announced Ascendia’s patented Emulsol® nanotechnology has been used to develop a novel nanoemulsion IV formulation for….
SPECIAL FEATURE - Outsourcing Formulation Development & Manufacturing: Putting Customers First June 5, 2023
Contributor Cindy H. Dubin speaks with several leading CDMOs from around the globe on their unique development and manufacturing capabilities and technologies, and presents real-world examples of how they have put these to use to produce innovative compounds, lower development costs, and shorten time to market.
PATIENTS-ON-A-CHIP - Why Artificial Intelligence Will Be the Tipping Point to Remove the Faulty Reliance on Animal Testing in Drug Discovery January 16, 2023
Isaac Bentwich, MD, believes Advanced Bio-AI platforms that integrate artificial intelligence and machine learning with patients-on-a-chip, real-time nano-sensing, and stem cell genomic diversity technologies are the future of drug discovery and development.
Synlogic Announces Synthetic Biotic for Gout Developed in Partnership With Ginkgo Bioworks August 11, 2022
Synlogic, Inc. recently announced a new drug candidate for the treatment of gout developed in partnership with Ginkgo Bioworks The new...Evonik Now Offers Enteric-Protected Ready-to-Fill Capsules – EUDRACAP- in IPEC-GMP Quality July 12, 2022
Evonik’s EUDRACAP enteric easy-to-handle capsules are now globally available produced under IPEC-GMP. Launched last year, EUDRACAP enteric are….
Evonik Launches Non-Animal-Derived Collagen Platform at Commercial Scale for Medical Device Applications July 5, 2022
Evonik’s recombinant, non-animal-derived collagen platform is now available at commercial scale. Vecollan is a highly pure and soluble collagen that...
